Erin Quirk
2022
In 2022, Erin Quirk earned a total compensation of $1.1M as President, Head of Research & Development at Terns Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,760 |
|---|---|
| Option Awards | $321,103 |
| Salary | $475,200 |
| Other | $12,200 |
| Total | $1,129,263 |
Quirk received $475.2K in salary, accounting for 42% of the total pay in 2022.
Quirk also received $320.8K in non-equity incentive plan, $321.1K in option awards and $12.2K in other compensation.
Rankings
In 2022, Erin Quirk's compensation ranked 2,801st out of 5,760 executives tracked by ExecPay. In other words, Quirk earned more than 51.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,801 out of 5,760 | 51st |
Division Manufacturing | 1,561 out of 3,136 | 50th |
Major group Chemicals And Allied Products | 725 out of 1,422 | 49th |
Industry group Drugs | 677 out of 1,323 | 49th |
Industry Pharmaceutical Preparations | 490 out of 969 | 49th |
Source: SEC filing on April 28, 2023.
Quirk's colleagues
We found two more compensation records of executives who worked with Erin Quirk at Terns Pharmaceuticals in 2022.